GSI [GENERAL STEEL] CORRESP: April 5, 2012 Via E-mail EDGAR 100 F

[April 5, 2012 Via E-mail EDGAR 100 F Street, N.E. Re: General Steel Holdings, Inc. Form 10-K for the Fiscal Year Ended December 31, 2010 Filed March 16, 2011 Form 10-Q for the Fiscal Quarter Ended March 31, 2011 Filed May 10, 2011 File No. 1-33717 Ladies and Gentlemen: This letter from General Steel Holdings, Inc. (hereinafter “we” or the]

HIMX [Himax Technologies] 6-K: Himax Technologies Raises First Quarter Revenue, Gross Margin

[Himax Technologies Raises First Quarter Revenue, Gross Margin and EPS Guidance TAINAN, Taiwan, April 5, 2012 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. ("Himax" or "Company") (Nasdaq:HIMX) today announced that it expects its first quarter revenues, gross margin and EPS to exceed the Company's previously announced guidance on February 13, 2012. Himax is revising its first quarter revenue guidance to $166.7] [FORM 6-K April 2012 000-51847 Himax Technologies, Inc. No.26, Zih Lian Road, Fonghua Village, Note: Note: Himax Technologies, Inc. Chief Financial Officer 6-K 1 document.htm FORM 6-K FILING DOCUMENT]

By | 2016-03-23T12:49:47+00:00 April 5th, 2012|Categories: Chinese Stocks, HIMX, Webplus ver|Tags: , , , , , |0 Comments

CTC [IFM Investments] F-6 POS: ____________________ POST-EFFECTIVE AMENDMENT NO.1 TO FORM F-6 REGISTRATION

[____________________ POST-EFFECTIVE AMENDMENT NO.1 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts IFM INVESTMENTS LIMITED N/A The Cayman Islands (Jurisdiction of incorporation or organization of issuer) JPMORGAN CHASE BANK, N.A. (Exact name of depositary as specified in its charter) 1 Chase Manhattan Plaza, Floor 21, New York, NY, 10005-1401] [J.P.Morgan AMENDMENT NO. 1, W I T N E S S E T H WHEREAS, the Company and the Depositary executed the Deposit Agreement for the purposes set forth therein; and NOW, THEREFORE, ARTICLE I DEFINITIONS SECTION 1.01. Definitions ARTICLE II AMENDMENTS TO DEPOSIT AGREEMENT SECTION 2.01. SECTION 2.02. SECTION 2.03. In connection with the deposit of Shares hereunder, the] [Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A. represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (IFM Investments Limited, 333-164239) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and time]

JFC [JPMORGAN CHINA REGION FUND,] CORRESP: April 5, 2012mment Pleased a pro forma fee

[April 5, 2012mment Pleased a pro forma fee table, which willlude the estimated interest expense of borrowing 20% of netsets. Response The future impact of interest expense on the Funds fees is unclear, but it is not the subject of this proxy statement. The Fund sought shareholder approval for borrowing last year. This proposal relates]

By | 2016-01-13T09:14:17+00:00 April 5th, 2012|Categories: Chinese Stocks, JFC, Webplus ver|Tags: , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION

[ARTICLES OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOSTAR PHARMACEUTICALS, INC. This is to certify that: FIRST SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Inc. Ronghua Wang Shuang Gong Chief Executive Officer Secretary EX-3.1 2 ex3-1.htm] [BIOSTAR PHARMACEUTICALS TO EFFECT REVERSE STOCK SPLIT -- XIANYANG, China, April 3, 2012 As a result of the reverse stock split, the number of outstanding common shares will be reduced to approximately 9,398,892. Fractional stockholdings will be rounded up to the nearest whole number. The reverse stock split will affect all stockholders uniformly and will not affect any stockholder’s ownership]

By | 2016-03-03T12:08:17+00:00 April 4th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: ARTICLES OF AMENDMENT TO THE ARTICLES OFORPORATION OF

[ARTICLES OF AMENDMENT TO THE ARTICLES OFORPORATION OF BIOSTAR PHARMACEUTICALS, This is to certify that: SECOND THIRD FOURTH IN WITNESS WHEREOF Biostar Pharmaceuticals, Ronghua Wang Shuang Gong Chief Executive Officer Secretary ex3-1.htm 2 EX-3.1] [BIOSTAR PHARMACEUTICALS TO EFFECT REVERSE STOCKLIT -- XIANYANG, China, April 3, 2012 a result of the reverse stocklit, the number of outstandingmmon shares will be reduced to approximately 9,398,892.Fractional stockholdings will be rounded up to the nearest whole number.The reverse stocklit will affectl stockholders uniformly and will not affect any stockholders ownership percentage of the]

By | 2016-02-07T15:53:10+00:00 April 4th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

GSOL [GLOBAL SOURCES] 6-K: The Company’s shares trading on NASDAQ was halted

[The Company's shares trading on NASDAQ was halted on April 3, 2012 at 10:13:42 a.m. Eastern Time by NASDAQ for an “additional information request”, which was subsequently provided by the Company. The trading of the Company’s shares is scheduled to resume on Wednesday, April 4, 2012, at 7:15 a.m. Eastern Time. GLOBAL SOURCES LTD.]

By | 2016-03-07T18:03:01+00:00 April 4th, 2012|Categories: Chinese Stocks, GSOL, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar